Trials / Terminated
TerminatedNCT00623025
Creon in HIV Patients With Steatorrhea
Double-blind, Cross-over, Randomized, Placebo-controlled, Multi-center Study to Investigate the Effect of Creon®25 000 on the Coefficient of Fat Absorption of HIV-infected Patients
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study investigates the effect of pancreatic enzymes on steatorrhea in HIV patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Creon 25000 | 6 to 9 capsules Creon 25000 per day |
| DRUG | Placebo | 6 to 9 capsules placebo per day |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2008-02-25
- Last updated
- 2011-08-01
Locations
2 sites across 1 country: Romania
Source: ClinicalTrials.gov record NCT00623025. Inclusion in this directory is not an endorsement.